All stock lists
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
437.79+3.55 (+0.82%)
Insider Score
––Not scored
MDGL Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
MDGL analyst forecast
MDGL analyst consensus
No analyst ratings in the last 3 months.
MDGL 12-month price target
$735.00+66.3% upsideaverage of 1 firm
$735.00High
$735.00Low
Best analysts covering MDGL
No firm covering MDGL has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
MDGL analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| UBS | — | $735.00 | +62.6% | — | 2026-10-14 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.